|    According to Lux Research’s Matthew Nordan, two companies  - Nanosys and QDC - claim to have divvied up  exclusive licenses to all key patents on quantum dots, with QDClaying claim  to biological applications and Nanosys claiming everything else. Founded in  1998, QDC develops and sells semiconductor nanocrystals for biological,  biochemical and biomedical applications. QDC has licensed 22 patents and owns  or has licensed over 90 US and international patent applications currently  under examination.   The Conflict Between QDC  and Evident Technologies Regarding Water-Soluble Semiconductor Nanocrystals  QDC asserts that “only QDC can provide…licensed  water-soluble nanocrystal-linker compounds for biological uses.” Nonetheless,  Evident Technologies of Troy,  NY (USA) markets proprietary water-soluble semiconductor nanocrystals for  biomolecule detection. Evident says they are not infringing QDC’s patents,  but as Lux’s Nordan points out, “one of these two standpoints is wrong.”    How the Lack of a  Standardized Vocabulary for Processing Quantum Dots Can Lead to Problems  The lack of standardized terminology may have led to the  granting of over-lapping patents, with claims that read very differently but  do in fact describe the same processes or products. For example, a broad  patent search using keywords (including semiconductor nanocrystals, quantum dot, nanodot)  brings up only one of Evident’s five patents, all of which refer to prior art  related to the optical effects of nanocrystals.    Table 1. Patents on quantum dots  issued by the US PTO from 1999 to 2004 (survey conducted on 2 May 2005).            |          |                    |      MIT      |          USA      |          15      |            |      University of    California      |          USA      |          12      |            |      Quantum Dot Corporation      |          USA      |          10      |            |      Technology & Devices Intl.      |          USA      |          7      |            |      IBM      |                 |          7      |            |      Sony Corporation      |          Japan      |          7      |            |      University of Illinois      |          USA      |          6      |            |      Texas    Instruments      |          USA      |          6      |            |      Electronics and Telecommunications Research      |          Korea      |          6      |            |      Matsushita Electric    Industrial     Co., Ltd.      |          Japan      |          5      |            |      Fujitsu Limited      |          Japan      |          5      |             Patenting Quantum Dots - a  Summary of the Current Situation and Future Trends  •        ETC Group’s list of top quantum dot patent  assignees reveals that university labs have actively pursued patents on  quantum dot related research. The concentration in ownership of key quantum  dot patents (especially the dominant positions of Nanosys and Quantum Dot  Corporation)is obscured, however, partly because patent assignees are  not disclosed.   •        There is enormous potential for overlapping  and conflicting patents in the quantum dot arena. The 146 patents issued by  the USPTO from 1999-2004 on quantum dots technology had 71 different patent  examiners. Different examiners in different departments may have reviewed  different prior art, leading to the issuance of patents that might otherwise  be rejected.   •        While the number of US patents related to  quantum dots did not experience dramatic growth from 2001-2004, patent  applications in the area of quantum dots are increasing every year. The trend  suggests that patent activity in this area will be even more crowded, and  complex, in the immediate future.    |